In comparison with the PCOS-IR group, the PCOS-IR+GPR120 agonist, PCOS-IR+LrB (40 mg/kg), and PCOS-IR+LrB (20 mg/kg) groups presented significant increases in GPR120 mRNA and protein (Figure 10A,C), while the PCOS-IR+LrB (10 mg/kg) group showed significant increases in GPR120 mRNA and protein expression (Figure 10A,C). Here, FFAR4 is linked to polycystic ovary syndrome.